↓ Skip to main content

Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, April 2017
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (61st percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
1 X user
patent
1 patent

Citations

dimensions_citation
83 Dimensions

Readers on

mendeley
98 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2
Published in
Journal of Experimental & Clinical Cancer Research, April 2017
DOI 10.1186/s13046-017-0530-4
Pubmed ID
Authors

Wei Li, Mengzhu Zheng, Shuangping Wu, Suyu Gao, Mei Yang, Zhimei Li, Qiuxia Min, Weiguang Sun, Lixia Chen, Guangya Xiang, Hua Li

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 98 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 17 17%
Student > Bachelor 17 17%
Researcher 15 15%
Other 4 4%
Student > Doctoral Student 4 4%
Other 12 12%
Unknown 29 30%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 19 19%
Pharmacology, Toxicology and Pharmaceutical Science 13 13%
Agricultural and Biological Sciences 10 10%
Chemistry 9 9%
Neuroscience 5 5%
Other 9 9%
Unknown 33 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 October 2023.
All research outputs
#8,306,033
of 25,483,400 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#539
of 2,396 outputs
Outputs of similar age
#122,487
of 324,449 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#8
of 22 outputs
Altmetric has tracked 25,483,400 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 2,396 research outputs from this source. They receive a mean Attention Score of 4.8. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 324,449 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.